1887

Abstract

A case of invasive pulmonary aspergillosis caused by is described. The diagnosis was based on demonstration of branched septate hyphae in a sputum specimen and isolation of the fungus in culture. The diagnosis was further supported by detection of -specific DNA, galactomannan (GM) and (1→3)---glucan (BDG) in consecutive serum specimens. The patient was treated for about 10 weeks with voriconazole. The decreasing levels of GM and BDG in serum samples were accompanied by symptomatic and radiological improvement. The report highlights the value of surrogate markers in the diagnosis and for monitoring the course of invasive aspergillosis during therapy.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.023630-0
2010-12-01
2019-11-22
Loading full text...

Full text loading...

/deliver/fulltext/jmm/59/12/1519.html?itemId=/content/journal/jmm/10.1099/jmm.0.023630-0&mimeType=html&fmt=ahah

References

  1. Ahmad, S., Khan, Z. U. & Theyyathel, A. M. ( 2007; ). Diagnostic value of DNA, (1–3)-β-d-glucan, and galactomannan detection in serum and bronchoalveolar lavage of mice experimentally infected with Aspergillus terreus. Diagn Microbiol Infect Dis 59, 165–171.[CrossRef]
    [Google Scholar]
  2. Baddley, J. W., Pappas, P. G., Smith, A. C. & Moser, S. A. ( 2003; ). Epidemiology of Aspergillus terreus at a university hospital. J Clin Microbiol 41, 5525–5529.[CrossRef]
    [Google Scholar]
  3. Blum, G., Perkhofer, S., Grif, K., Mayr, A., Kropshofer, G., Nachbaur, D., Kafka-Ritsch, R., Dierich, M. P. & Lass-Flörl, C. ( 2008; ). A 1-year Aspergillus terreus surveillance study at the University Hospital of Innsbruck: molecular typing of environmental and clinical isolates. Clin Microbiol Infect 14, 1146–1151.[CrossRef]
    [Google Scholar]
  4. Castón, J. J., Linares, M. J., Gallego, C., Rivero, A., Font, P., Solís, F., Casal, M. & Torre-Cisneros, J. ( 2007; ). Risk factors for pulmonary Aspergillus terreus infection in patients with positive culture for filamentous fungi. Chest 131, 230–236.[CrossRef]
    [Google Scholar]
  5. Curtis, L., Cali, S., Conroy, L., Baker, K., Ou, C. H., Hershow, R., Norlock-Cruz, F. & Scheff, P. ( 2005; ). Aspergillus surveillance project at a large tertiary-care hospital. J Hosp Infect 59, 188–196.[CrossRef]
    [Google Scholar]
  6. Deak, E., Wilson, S. D., White, E., Carr, J. H. & Balajee, S. A. ( 2009; ). Aspergillus terreus accessory conidia are unique in surface architecture, cell wall composition and germination kinetics. PLoS ONE 4, e7673.[CrossRef]
    [Google Scholar]
  7. Guinea, J., Peláez, T., Alcalá, L. & Bouza, E. ( 2006; ). Outdoor environmental levels of Aspergillus spp. conidia over a wide geographical area. Med Mycol 44, 349–356.
    [Google Scholar]
  8. Hachem, R. Y., Kontoyiannis, D. P., Boktour, M. R., Afif, C., Cooksley, C., Bodey, G. P., Chatzinikolaou, I., Perego, C., Kantarjian, H. M. & Raad, I. I. ( 2004; ). Aspergillus terreus: an emerging amphotericin B-resistant opportunistic mold in patients with hematologic malignancies. Cancer 101, 1594–1600.[CrossRef]
    [Google Scholar]
  9. Hachem, R. Y., Kontoyiannis, D. P., Chemaly, R. F., Jiang, Y., Reitzel, R. & Raad, I. ( 2009; ). Utility of galactomannan enzyme immunoassay and (1,3) beta-d-glucan in diagnosis of invasive fungal infections: low sensitivity for Aspergillus fumigatus infection in hematologic malignancy patients. J Clin Microbiol 47, 129–133.[CrossRef]
    [Google Scholar]
  10. Herbrecht, R., Denning, D. W., Patterson, T. F., Bennett, J. E., Greene, R. E., Oestmann, J. W., Kern, W. V., Marr, K. A., Ribaud, P. & other authors ( 2002; ). Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 347, 408–415.[CrossRef]
    [Google Scholar]
  11. Kedzierska, A., Kochan, P., Pietrzyk, A. & Kedzierska, J. ( 2007; ). Current status of fungal cell wall components in the immunodiagnostics of invasive fungal infections in humans: galactomannan, mannan and (1→3)-beta-d-glucan antigens. Eur J Clin Microbiol Infect Dis 26, 755–766.[CrossRef]
    [Google Scholar]
  12. Khan, Z. U., Khan, M. A., Chandy, R. & Sharma, P. N. ( 1999a; ). Aspergillus and other moulds in the air of Kuwait. Mycopathologia 146, 25–32.[CrossRef]
    [Google Scholar]
  13. Khan, Z. U., Kortom, M., Marouf, R., Jamal, W. & Chandy, R. ( 1999b; ). Fatal pulmonary aspergillosis due to Aspergillus terreus. J Mycol Med 9, 166–169.
    [Google Scholar]
  14. Khan, Z. U., Kortom, M., Marouf, R., Chandy, R., Rinaldi, M. G. & Sutton, D. A. ( 2000; ). Bilateral pulmonary aspergilloma caused by an atypical isolate of Aspergillus terreus. J Clin Microbiol 38, 2010–2014.
    [Google Scholar]
  15. Khan, Z. U., Ahmad, S., Mokaddas, E., Said, T., Nair, M. P., Halim, M. A., Nampoory, M. R. & McGinnis, M. R. ( 2007; ). Cerebral aspergillosis diagnosed by detection of Aspergillus flavus-specific DNA, galactomannan and (1→3)-β-d-glucan in clinical specimens. J Med Microbiol 56, 129–132.[CrossRef]
    [Google Scholar]
  16. Khan, Z. U., Ahmad, S. & Theyyathel, A. M. ( 2008; ). Detection of Aspergillus fumigatus-specific DNA, (1–3)-β-d-glucan and galactomannan in serum and bronchoalveolar lavage specimens of experimentally infected rats. Mycoses 51, 129–135.[CrossRef]
    [Google Scholar]
  17. Koo, S., Bryar, J. M., Baden, L. R. & Marty, F. M. ( 2010; ). Prognostic features of galactomannan antigenemia in galactomannan-positive invasive aspergillosis. J Clin Microbiol 48, 1255–1260.[CrossRef]
    [Google Scholar]
  18. Lass-Flörl, C., Kofler, G., Kropshofer, G., Hermans, J., Kreczy, A., Dierich, M. P. & Niederwieser, D. ( 1998; ). In vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosis. J Antimicrob Chemother 42, 497–502.[CrossRef]
    [Google Scholar]
  19. Lass-Flörl, C., Griff, K., Mayr, A., Petzer, A., Gastl, G., Bonatti, H., Freund, M., Kropshofer, G., Dierich, M. P. & Nachbaur, D. ( 2005; ). Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience. Br J Haematol 131, 201–207.[CrossRef]
    [Google Scholar]
  20. Lass-Flörl, C., Alastruey-Izquierdo, A., Cuenca-Estrella, M., Perkhofer, S. & Rodriguez-Tudela, J. L. ( 2009; ). In vitro activities of various antifungal drugs against Aspergillus terreus: global assessment using the methodology of the European Committee on Antimicrobial Susceptibility Testing. Antimicrob Agents Chemother 53, 794–795.[CrossRef]
    [Google Scholar]
  21. Marty, F. M. & Koo, S. ( 2009; ). Role of (1→3)-β-d-glucan in the diagnosis of invasive aspergillosis. Med Mycol 47, S233–S240.[CrossRef]
    [Google Scholar]
  22. Mennink-Kersten, M. A., Ruegebrink, D., Wasei, N., Melchers, W. J. & Verweij, P. E. ( 2006; ). In vitro release by Aspergillus fumigatus of galactofuranose antigens, 1,3-beta-d-glucan, and DNA, surrogate markers used for diagnosis of invasive aspergillosis. J Clin Microbiol 44, 1711–1718.[CrossRef]
    [Google Scholar]
  23. Obayashi, T., Negishi, K., Suzuki, T. & Funata, N. ( 2008; ). Reappraisal of the serum (1→3)-β-d-glucan assay for the diagnosis of invasive fungal infections – a study based on autopsy cases from 6 years. Clin Infect Dis 46, 1864–1870.[CrossRef]
    [Google Scholar]
  24. Ostrosky-Zeichner, L. ( 2008; ). Biomarkers for diagnosis and disease monitoring. J Invasive Fungal Infect 2, 242–245.
    [Google Scholar]
  25. Pazos, C., Pontón, J. & Del Palacio, A. ( 2005; ). Contribution of (1→3)-β-d-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan. J Clin Microbiol 43, 299–305.[CrossRef]
    [Google Scholar]
  26. Pickering, J. W., Sant, H. W., Bowles, C. A., Roberts, W. L. & Woods, G. L. ( 2005; ). Evaluation of a (1→3)-β-d-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol 43, 5957–5962.[CrossRef]
    [Google Scholar]
  27. Sanguinetti, M., Posteraro, B., Pagano, L., Pagliari, G., Fianchi, L., La Sorda, M., Franco, A. & Fadda, G. ( 2003; ). Comparison of real-time PCR, conventional PCR, and galactomannan antigen detection by enzyme-linked immunosorbent assay using bronchoalveolar lavage fluid samples from hematology patients for diagnosis of invasive pulmonary aspergillosis. J Clin Microbiol 41, 3922–3925.[CrossRef]
    [Google Scholar]
  28. Senn, L., Robinson, J. O., Schmidt, S., Knaup, M., Asahi, N., Satomura, S., Matsuura, S., Duvoisin, B., Bille, J. & other authors ( 2008; ). 1,3-Beta-d-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia. Clin Infect Dis 46, 878–885.[CrossRef]
    [Google Scholar]
  29. Sherif, R. & Segal, B. H. ( 2010; ). Pulmonary aspergillosis: clinical presentation, diagnostic tests, management and complications. Curr Opin Pulm Med 16, 242–250.
    [Google Scholar]
  30. Steinbach, W. J., Benjamin, D. K., Jr, Kontoyiannis, D. P., Perfect, J. R., Lutsar, I., Marr, K. A., Lionakis, M. S., Torres, H. A., Jafri, H. & other authors ( 2004; ). Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases. Clin Infect Dis 39, 192–198.[CrossRef]
    [Google Scholar]
  31. Sutton, D. A., Sanche, S. E., Revankar, S. G., Fothergill, A. W. & Rinaldi, M. G. ( 1999; ). In vitro amphotericin B resistance in clinical isolates of Aspergillus terreus, with a head-to-head comparison to voriconazole. J Clin Microbiol 37, 2343–2345.
    [Google Scholar]
  32. Vandewoude, K. H., Blot, S. I., Depuydt, P., Benoit, D., Temmerman, W., Colardyn, F. & Vogelaers, D. ( 2006; ). Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients. Crit Care 10, R31.[CrossRef]
    [Google Scholar]
  33. Vonberg, R. P. & Gastmeier, P. ( 2006; ). Nosocomial aspergillosis in outbreak settings. J Hosp Infect 63, 246–254.[CrossRef]
    [Google Scholar]
  34. Walsh, T. J., Anaissie, E. J., Denning, D. W., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Segal, B. H., Steinbach, W. J. & other authors ( 2008; ). Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 46, 327–360.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.023630-0
Loading
/content/journal/jmm/10.1099/jmm.0.023630-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error